Nexalin Technology, Inc. (NXLIW)
USD 0.17
(20.14%)
USD 0.17
(20.14%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -5.69 Million USD | -210.76% |
| 2022 | -1.83 Million USD | 69.54% |
| 2021 | -6.01 Million USD | -84.71% |
| 2020 | -3.25 Million USD | -122.24% |
| 2019 | -1.46 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.29 Million USD | -20.8% |
| 2024 Q1 | -1.07 Million USD | 33.9% |
| 2023 Q4 | -1.62 Million USD | 32.75% |
| 2023 FY | -5.69 Million USD | -210.76% |
| 2023 Q3 | -2.41 Million USD | -175.48% |
| 2023 Q2 | -876.86 Thousand USD | -12.5% |
| 2023 Q1 | -779.42 Thousand USD | -8.31% |
| 2022 Q2 | -445.1 Thousand USD | -18.66% |
| 2022 Q1 | -375.11 Thousand USD | 35.04% |
| 2022 FY | -1.83 Million USD | 69.54% |
| 2022 Q4 | -719.61 Thousand USD | -145.44% |
| 2022 Q3 | -293.19 Thousand USD | 34.13% |
| 2021 Q3 | -1.79 Million USD | 13.75% |
| 2021 FY | -6.01 Million USD | -84.71% |
| 2021 Q4 | -577.48 Thousand USD | 67.84% |
| 2021 Q2 | -2.08 Million USD | -33.11% |
| 2021 Q1 | -1.56 Million USD | -319.42% |
| 2020 Q2 | -1.07 Million USD | 0.0% |
| 2020 FY | -3.25 Million USD | -122.24% |
| 2020 Q4 | -372.87 Thousand USD | 49.36% |
| 2020 Q3 | -736.39 Thousand USD | 31.47% |
| 2020 Q1 | -1.07 Million USD | 0.0% |
| 2019 FY | -1.46 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 60.335% |
| Cerus Corporation | -30.05 Million USD | 81.046% |
| OrthoPediatrics Corp. | -25.76 Million USD | 77.892% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 46.369% |
| Talis Biomedical Corporation | -66.81 Million USD | 91.475% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 67.066% |
| Inogen, Inc. | -109.38 Million USD | 94.792% |
| Spectral AI, Inc. | -12.98 Million USD | 56.128% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 90.899% |
| CVRx, Inc. | -43.1 Million USD | 86.784% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -61.46% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 54.166% |
| Orthofix Medical Inc. | -139.11 Million USD | 95.905% |
| Venus Concept Inc. | -28.3 Million USD | 79.878% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 89.457% |
| Bioventus Inc. | -81.72 Million USD | 93.03% |
| BrainsWay Ltd. | -4.92 Million USD | -15.614% |
| Envoy Medical, Inc. | -18.37 Million USD | 68.993% |
| electroCore, Inc. | -18.8 Million USD | 69.709% |
| IceCure Medical Ltd | -15.57 Million USD | 63.429% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 88.251% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 67.012% |
| MaxCyte, Inc. | -48.29 Million USD | 88.206% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 52.353% |
| PAVmed Inc | -68.79 Million USD | 91.72% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 89.929% |
| RxSight, Inc. | -50.08 Million USD | 88.627% |
| Sight Sciences, Inc. | -57.27 Million USD | 90.054% |
| SI-BONE, Inc. | -46.93 Million USD | 87.862% |
| TELA Bio, Inc. | -44.07 Million USD | 87.076% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 89.481% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 88.924% |
| LivaNova PLC | -68.49 Million USD | 91.684% |
| 908 Devices Inc. | -42.75 Million USD | 86.678% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 96.715% |
| Nemaura Medical Inc. | -9.59 Million USD | 40.634% |
| NeuroPace, Inc. | -27.17 Million USD | 79.038% |
| LENSAR, Inc. | -12.22 Million USD | 53.42% |
| Apyx Medical Corporation | -17.25 Million USD | 66.995% |
| Cutera, Inc. | -156.23 Million USD | 96.354% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 33.795% |
| BioSig Technologies, Inc. | -28.51 Million USD | 80.021% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 93.5% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 74.622% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 105.108% |
| Axonics, Inc. | -26.05 Million USD | 78.139% |
| Outset Medical, Inc. | -169.77 Million USD | 96.645% |
| IRIDEX Corporation | -10 Million USD | 43.077% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 94.782% |
| IRadimed Corporation | 20.03 Million USD | 128.431% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 30.912% |
| INVO Bioscience, Inc. | -6.76 Million USD | 15.824% |
| Telesis Bio, Inc. | -35.15 Million USD | 83.794% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 139.751% |
| Varex Imaging Corporation | 32.1 Million USD | 117.745% |
| Quipt Home Medical Corp. | 3.91 Million USD | 245.351% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 53.051% |
| Pulmonx Corporation | -61.93 Million USD | 90.803% |
| Dynatronics Corporation | -2.27 Million USD | -150.602% |
| Modular Medical, Inc. | -17.52 Million USD | 67.504% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 61.088% |
| Semler Scientific, Inc. | 22.25 Million USD | 125.594% |
| InMode Ltd. | 195.66 Million USD | 102.911% |
| Bruker Corporation | 436.9 Million USD | 101.304% |
| Cytosorbents Corporation | -31.2 Million USD | 81.748% |
| DexCom, Inc. | 597.7 Million USD | 100.953% |
| Align Technology, Inc. | 643.33 Million USD | 100.885% |
| Viveve Medical, Inc. | -21.55 Million USD | 73.571% |
| ZimVie Inc. | -30.93 Million USD | 81.589% |
| Movano Inc. | -29.69 Million USD | 80.814% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 79.543% |
| Nexalin Technology, Inc. | -5.69 Million USD | -0.0% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -61.46% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 97.558% |
| Profound Medical Corp. | -28.61 Million USD | 80.094% |
| Insulet Corporation | 220 Million USD | 102.589% |
| enVVeno Medical Corporation | -25.23 Million USD | 77.43% |
| Surmodics, Inc. | -5.64 Million USD | -0.909% |
| iCAD, Inc. | -7.68 Million USD | 25.916% |
| Nuwellis, Inc. | -17.63 Million USD | 67.69% |
| Biotricity, Inc. | -8.82 Million USD | 35.477% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 95.449% |
| Aethlon Medical, Inc. | -12.63 Million USD | 54.922% |
| InspireMD, Inc. | -21.14 Million USD | 73.058% |
| PAVmed Inc. | -68.79 Million USD | 91.72% |
| BIOLASE, Inc. | -17.93 Million USD | 68.243% |
| Beyond Air, Inc. | -63 Million USD | 90.959% |
| FONAR Corporation | 16.53 Million USD | 134.449% |
| AxoGen, Inc. | -21.46 Million USD | 73.459% |
| Vivani Medical, Inc. | -26.96 Million USD | 78.875% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 131.574% |
| Inari Medical, Inc. | -14.03 Million USD | 59.405% |
| UFP Technologies, Inc. | 57.66 Million USD | 109.878% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -15.6% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 9.665% |
| Tenon Medical, Inc. | -15.72 Million USD | 63.78% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 23.785% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 86.662% |
| AdaptHealth Corp. | -598.4 Million USD | 99.048% |
| Sintx Technologies, Inc. | -13.35 Million USD | 57.357% |
| NanoVibronix, Inc. | -3.43 Million USD | -65.783% |
| Quanterix Corporation | -49.7 Million USD | 88.539% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 53.051% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -1391.177% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 98.297% |
| TransMedics Group, Inc. | -28.72 Million USD | 80.171% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 75.875% |
| NeuroMetrix, Inc. | -7.15 Million USD | 20.348% |
| Hyperfine, Inc. | -48.11 Million USD | 88.161% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 91.24% |
| Biomerica, Inc. | -6.36 Million USD | 10.534% |
| Bone Biologics Corporation | -9.42 Million USD | 39.583% |
| AVITA Medical, Inc. | -40.4 Million USD | 85.901% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 44.756% |
| Silk Road Medical, Inc | -59.27 Million USD | 90.389% |